Gardasill 9™ vaccine
C/39/2018
Phase 3 mab completed
Quick answer
Gardasill 9™ vaccine for Neoplasia is a Phase 3 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Neoplasia
- Phase
- Phase 3
- Modality
- mab
- Status
- completed